These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38180601)

  • 1. Vitality, viability, long-term clonogenic survival, cytotoxicity, cytostasis and lethality: what do they mean when testing new investigational oncology drugs?
    Forgie BN; Prakash R; Goyeneche AA; Telleria CM
    Discov Oncol; 2024 Jan; 15(1):5. PubMed ID: 38180601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is cell death a critical end point for anticancer therapies or is cytostasis sufficient?
    Rixe O; Fojo T
    Clin Cancer Res; 2007 Dec; 13(24):7280-7. PubMed ID: 18094408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
    Gautam P; Karhinen L; Szwajda A; Jha SK; Yadav B; Aittokallio T; Wennerberg K
    Mol Cancer; 2016 May; 15(1):34. PubMed ID: 27165605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between surviving clonogenic crypt fraction and animal lethality after cytosine arabinoside (Ara-C) exposure.
    Pallavicini MG; Ng CR; Gray JW
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 46(1-2):33-42. PubMed ID: 6147927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kill and cytostasis by ET-18-OCH3 and heat.
    Fujiwara K; Modest EJ; Wallen CA
    Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
    Bromfield GP; Meng A; Warde P; Bristow RG
    Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of conventional cell viability assays for reliable and reproducible read-outs: experimental evidence.
    Garg S; Huifu H; Kaul SC; Wadhwa R
    BMC Res Notes; 2018 Jun; 11(1):403. PubMed ID: 29929534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of methods used for assessing the viability and vitality of yeast cells.
    Kwolek-Mirek M; Zadrag-Tecza R
    FEMS Yeast Res; 2014 Nov; 14(7):1068-79. PubMed ID: 25154541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition.
    Subeha MR; Goyeneche AA; Bustamante P; Lisio MA; Burnier JV; Telleria CM
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supraphysiological thermal injury in Dunning AT-1 prostate tumor cells.
    Bhowmick S; Swanlund DJ; Bischof JC
    J Biomech Eng; 2000 Feb; 122(1):51-9. PubMed ID: 10790830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pharmacokinetic parameters in patients and cytotoxicity in vitro of standard and investigational anticancer drugs.
    Fridborg H; Nygren P; Larsson R
    Anticancer Drugs; 1995 Feb; 6(1):64-9. PubMed ID: 7756685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing the role of healthy volunteer studies in drug development.
    Karakunnel JJ; Bui N; Palaniappan L; Schmidt KT; Mahaffey KW; Morrison B; Figg WD; Kummar S
    J Transl Med; 2018 Dec; 16(1):336. PubMed ID: 30509294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.
    Williams BA; Wang XH; Keating A
    Cytotherapy; 2010 Nov; 12(7):951-60. PubMed ID: 20230219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?
    LoRusso PM; Anderson AB; Boerner SA; Averbuch SD
    Clin Cancer Res; 2010 Dec; 16(24):5956-62. PubMed ID: 21169248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma.
    Ardad RM; Manjappa AS; Dhawale SC; Kumbhar PS; Pore YV
    Drug Dev Ind Pharm; 2023 Dec; 49(5):377-391. PubMed ID: 37216496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.